2021
DOI: 10.1016/j.jvir.2021.03.266
|View full text |Cite
|
Sign up to set email alerts
|

Abstract No. 457 Initial experience of treating hepatocellular carcinoma with concomitant nivolumab and liver-directed therapies

Abstract: and median procedure time: 93.0 [IQR 54.5] and 71.0 [IQR 29.0], respectively). Conclusions: Findings suggest that increasing experience with performing PAE may decrease procedure time and radiation exposure to the patient and operator. A longitudinal study on PAE patients and their risk of radiation-induced deterministic and/or stochastic effects is recommended.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles